.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Clinicians are making significant strides in understanding SET-related neurodevelopmental disorder, a condition linked to the inhibitor of histone acetyltransferases (INHAT) complex. This gene plays a vital role in transcriptional silencing and gene regulation. Recent research has now expanded the known clinical and molecular spectrum of this rare condition. By analyzing 23 previously unreported individuals, scientists identified consistent patterns that assist in earlier and more accurate diagnosis.
Affected individuals typically present with global developmental delay. This delay often involves pronounced hypotonia and significant motor and language setbacks. Most cases eventually evolve into mild to moderate intellectual disability. Furthermore, common comorbidities include behavioral concerns and sleeping disturbances. Additionally, some patients exhibit variable, unspecific ocular problems. Consequently, the phenotypic spectrum is much broader than clinicians previously recognized.
Interestingly, researchers utilized next-generation computer-assisted phenotyping to study facial gestalt. They found limited overlapping features among affected individuals. This helps differentiate the condition from other disorders caused by related chromatin-modifying genes. Moreover, the study introduced a specific DNA methylation signature. This epigenetic marker distinguishes pathogenic variants in SET from other neurodevelopmental disorders and healthy controls. Therefore, clinicians can now use this signature to resolve variants of uncertain significance. These novel approaches provide a much clearer path for diagnosis and parental counseling. Indeed, these findings represent a major leap forward for precision medicine in genetics.
The primary symptoms include global developmental delay, hypotonia (low muscle tone), and delayed speech and motor development, which often lead to intellectual disability.
Diagnosis is usually achieved through next-generation sequencing. However, new DNA methylation signatures now allow clinicians to confirm the pathogenicity of rare variants more accurately.
Common comorbidities include behavioral issues, sleep disturbances, and various non-specific eye problems.
Disclaimer: This content is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Shi Y et al. Delineating the clinical and molecular spectrum of the neurodevelopmental disorder associated with SET. Genet Med. 2026 Jun 19. doi: undefined. PMID: 42322191.
Stevens SJ et al. SET de novo frameshift variants associated with developmental delay and intellectual disabilities. Eur J Med Genet. 2018;61(11):624-630.
Krzyzewska IM et al. A genome-wide DNA methylation signature for SETD1B-related syndrome. Clin Epigenetics. 2019;11:156.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study of 23 individuals clarifies the clinical spectrum of SET-related neurodevelopmental disorder. Key findings include global developmental delay, hypotonia, and a unique DNA methylation signature that improves diagnostic accuracy for this rare genetic condition.
4 months ago
Depemokimab offers twice-yearly dosing for severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps, significantly cutting exacerbations and hospital admissions.
3 days back
A novel copper metal-organic framework hydrogel remodels the uterine microenvironment to stimulate robust endometrial regeneration, reduce intrauterine fibrosis, and restore reproductive fertility, offering a groundbreaking strategy for managing refractory endometrial damage and Asherman syndrome.
4 days back
New research reveals that non-ablative radiotherapy suppresses ventricular tachycardia by increasing conduction velocity via NaV1.5 upregulation and action potential prolongation. However, sustained sodium current elevation and depressed calcium handling highlight the need for careful clinical translation.
6 days back
A single-cell transcriptomic atlas reveals how peripheral nerve injuries cause dorsal root ganglion remodeling. By evaluating proximal nerve crush and resection, researchers identify distinct glial and immune programs that resolve neuropathic pain and promote regeneration.
3 days back
A breakthrough study demonstrates that fullerol-primed extracellular vesicles generated in a 3D SECCS bioreactor attenuate ferroptosis and restore myogenic regeneration in diabetes via the FOXO3 pathway, offering a cell-free therapeutic strategy for diabetic musculoskeletal degeneration.
3 days back
